UNION, Ky., May 29 /PRNewswire/ -- Union Springs Pharmaceuticals, LLC, announced today it will now offer MyClyns in individually wrapped single units. These new packages provide enhanced tamper-proof protection for each MyClyns unit and also afford customers greater purchasing flexibility. Each sealed package will contain one MyClyns unit and a label card with directions for use and other important product information.
Furthermore, cases of MyClyns will now contain twenty-four single units rather than the eight three-packs found in previous cases. However, three- packs will be available for a short time while inventory lasts.
"Based on the feedback we have received from our customers, we are now pleased to offer individually packaged units for our customers," said Joel Ivers, President of Union Springs Pharmaceuticals. He added, "Customers wanted an easy way to determine whether a unit had been opened and they wanted the convenience to purchase one unit at a time. We satisfied both of these requests with one packaging solution."
MyClyns contains a fast-acting solution with germ-killing action that is safe to use on all mucous membranes including the eyes, ears, nose, mouth, and on open wounds. MyClyns' convenient pen-like design allows first responders to protect themselves immediately after exposure to potentially harmful pathogens when other alternatives are not available. Significantly, MyClyns is the only product on the market that can be safely used on the face. MyClyns is intended for immediate use by emergency medical, police, fire, corrections, military, healthcare providers, homeland security, and others exposed to bodily fluids.
MyClyns(TM) (a pen-like device) is the only convenient, non-alcohol, first response spray providing personal protection immediately after a potentially pathogenic exposure. MyClyns contains a fast-acting solution with germ- killing action that is safe to use on all mucous membranes, including the eyes, nose, ears, mouth and on open wounds. Independent laboratory tests show that the solution in MyClyns demonstrated a 99.99% reduction in HIV-1, Hepatitis C, MRSA, C-diff and many other pathogens. MyClyns allows personnel to protect themselves after a pathogenic exposure when complete post-exposure protocols are rarely available. Visit the MyClyns website at http://www.myclyns.com for more information.
About Union Springs Pharmaceuticals, LLC
Union Springs Pharmaceuticals, LLC (USP) specializes in providing innovative over-the-counter (OTC) products for the consumer and healthcare markets. USP licenses, acquires, develops, and commercializes innovative products and technologies that satisfy the unmet needs of healthcare professionals and consumers. Union Springs Pharmaceuticals can be found on the Internet at http://www.uspharma.com
|SOURCE Union Springs Pharmaceuticals, LLC|
Copyright©2008 PR Newswire.
All rights reserved